Skanska USA
Update
06/30/23
Continuus Pharmaceuticals Cancels Woburn Project
Skanska has announced that Continuus Pharmaceuticals has canceled the project to build a pharmaceutical manufacturing facility in Woburn, Massachusetts, USA. The project was valued at roughly $122M. Plans had called for renovations and construction of a new 50,000-square-foot manufacturing facility within an existing shell building.
Search BLDUP
Search
BLDUP
for news, projects, and companies to find the information that pushes your business forward.
